| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | exogenous lipid antigen binding | 1.16e-08 | 5 | 22 | 3 | GO:0030884 | |
| GeneOntologyMolecularFunction | endogenous lipid antigen binding | 1.16e-08 | 5 | 22 | 3 | GO:0030883 | |
| GeneOntologyMolecularFunction | lipid antigen binding | 2.32e-08 | 6 | 22 | 3 | GO:0030882 | |
| GeneOntologyMolecularFunction | lipopeptide binding | 1.39e-07 | 10 | 22 | 3 | GO:0071723 | |
| GeneOntologyMolecularFunction | antigen binding | 1.14e-03 | 190 | 22 | 3 | GO:0003823 | |
| GeneOntologyMolecularFunction | amide binding | 4.15e-03 | 299 | 22 | 3 | GO:0033218 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation, endogenous lipid antigen via MHC class Ib | 9.08e-09 | 5 | 21 | 3 | GO:0048006 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation, exogenous lipid antigen via MHC class Ib | 3.18e-08 | 7 | 21 | 3 | GO:0048007 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of lipid antigen via MHC class Ib | 3.18e-08 | 7 | 21 | 3 | GO:0048003 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation via MHC class Ib | 2.06e-06 | 25 | 21 | 3 | GO:0002475 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous antigen | 4.43e-06 | 32 | 21 | 3 | GO:0019883 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell mediated cytotoxicity | 1.02e-05 | 42 | 21 | 3 | GO:0001916 | |
| GeneOntologyBiologicalProcess | regulation of T cell mediated cytotoxicity | 2.06e-05 | 53 | 21 | 3 | GO:0001914 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous antigen | 2.71e-05 | 58 | 21 | 3 | GO:0019884 | |
| GeneOntologyBiologicalProcess | T cell mediated cytotoxicity | 4.77e-05 | 70 | 21 | 3 | GO:0001913 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell mediated immunity | 5.63e-05 | 74 | 21 | 3 | GO:0002711 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte mediated cytotoxicity | 6.84e-05 | 79 | 21 | 3 | GO:0001912 | |
| GeneOntologyBiologicalProcess | regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 8.44e-05 | 235 | 21 | 4 | GO:0002822 | |
| GeneOntologyBiologicalProcess | positive regulation of cell killing | 9.44e-05 | 88 | 21 | 3 | GO:0031343 | |
| GeneOntologyBiologicalProcess | regulation of adaptive immune response | 1.11e-04 | 252 | 21 | 4 | GO:0002819 | |
| GeneOntologyBiologicalProcess | regulation of T cell mediated immunity | 1.88e-04 | 111 | 21 | 3 | GO:0002709 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte mediated cytotoxicity | 2.61e-04 | 124 | 21 | 3 | GO:0001910 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation | 3.64e-04 | 139 | 21 | 3 | GO:0019882 | |
| GeneOntologyBiologicalProcess | regulation of cell killing | 4.29e-04 | 147 | 21 | 3 | GO:0031341 | |
| GeneOntologyBiologicalProcess | positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 4.55e-04 | 150 | 21 | 3 | GO:0002824 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte mediated immunity | 4.55e-04 | 150 | 21 | 3 | GO:0002708 | |
| GeneOntologyBiologicalProcess | positive regulation of adaptive immune response | 5.40e-04 | 159 | 21 | 3 | GO:0002821 | |
| GeneOntologyBiologicalProcess | T cell mediated immunity | 5.80e-04 | 163 | 21 | 3 | GO:0002456 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte mediated immunity | 7.14e-04 | 175 | 21 | 3 | GO:0002705 | |
| GeneOntologyBiologicalProcess | leukocyte mediated cytotoxicity | 8.65e-04 | 187 | 21 | 3 | GO:0001909 | |
| GeneOntologyBiologicalProcess | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 1.10e-03 | 462 | 21 | 4 | GO:0002460 | |
| GeneOntologyBiologicalProcess | regulation of immune effector process | 1.44e-03 | 497 | 21 | 4 | GO:0002697 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte mediated immunity | 1.61e-03 | 232 | 21 | 3 | GO:0002706 | |
| GeneOntologyBiologicalProcess | regulation of reactive oxygen species biosynthetic process | 1.80e-03 | 62 | 21 | 2 | GO:1903426 | |
| GeneOntologyBiologicalProcess | reactive oxygen species biosynthetic process | 2.97e-03 | 80 | 21 | 2 | GO:1903409 | |
| GeneOntologyBiologicalProcess | cell killing | 3.56e-03 | 307 | 21 | 3 | GO:0001906 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte mediated immunity | 3.63e-03 | 309 | 21 | 3 | GO:0002703 | |
| GeneOntologyBiologicalProcess | positive regulation of immune effector process | 3.90e-03 | 317 | 21 | 3 | GO:0002699 | |
| GeneOntologyBiologicalProcess | regulation of immune response | 4.01e-03 | 1085 | 21 | 5 | GO:0050776 | |
| GeneOntologyCellularComponent | external side of plasma membrane | 1.05e-04 | 519 | 20 | 5 | GO:0009897 | |
| GeneOntologyCellularComponent | cell surface | 4.52e-04 | 1111 | 20 | 6 | GO:0009986 | |
| GeneOntologyCellularComponent | side of membrane | 1.16e-03 | 875 | 20 | 5 | GO:0098552 | |
| Domain | - | 1.24e-08 | 24 | 21 | 4 | 3.30.500.10 | |
| Domain | MHC_I-like_Ag-recog | 1.24e-08 | 24 | 21 | 4 | IPR011161 | |
| Domain | MHC_I_3 | 2.44e-08 | 6 | 21 | 3 | PF16497 | |
| Domain | MHC_I/II-like_Ag-recog | 8.50e-08 | 38 | 21 | 4 | IPR011162 | |
| Domain | C1-set | 3.60e-07 | 54 | 21 | 4 | PF07654 | |
| Domain | IGc1 | 4.18e-07 | 56 | 21 | 4 | SM00407 | |
| Domain | Ig_C1-set | 4.82e-07 | 58 | 21 | 4 | IPR003597 | |
| Domain | MHC_I_a_a1/a2 | 2.50e-04 | 21 | 21 | 2 | IPR001039 | |
| Domain | MHC_I | 2.50e-04 | 21 | 21 | 2 | PF00129 | |
| Domain | PYRIN | 2.74e-04 | 22 | 21 | 2 | SM01289 | |
| Domain | DAPIN | 2.74e-04 | 22 | 21 | 2 | PS50824 | |
| Domain | DAPIN | 2.74e-04 | 22 | 21 | 2 | IPR004020 | |
| Domain | PYRIN | 2.74e-04 | 22 | 21 | 2 | PF02758 | |
| Domain | NACHT | 3.00e-04 | 23 | 21 | 2 | PS50837 | |
| Domain | NACHT_NTPase | 3.00e-04 | 23 | 21 | 2 | IPR007111 | |
| Domain | - | 7.04e-04 | 663 | 21 | 5 | 2.60.40.10 | |
| Domain | Ig-like_fold | 9.35e-04 | 706 | 21 | 5 | IPR013783 | |
| Domain | LRR_6 | 1.72e-03 | 55 | 21 | 2 | PF13516 | |
| Domain | IG_LIKE | 1.98e-03 | 491 | 21 | 4 | PS50835 | |
| Domain | Ig-like_dom | 2.16e-03 | 503 | 21 | 4 | IPR007110 | |
| Domain | - | 4.84e-03 | 93 | 21 | 2 | 1.10.533.10 | |
| Domain | DEATH-like_dom | 5.47e-03 | 99 | 21 | 2 | IPR011029 | |
| Pathway | KEGG_HEMATOPOIETIC_CELL_LINEAGE | 1.20e-04 | 87 | 16 | 3 | M6856 | |
| Pubmed | A physical map linking the five CD1 human thymocyte differentiation antigen genes. | 2.19e-09 | 5 | 22 | 3 | 2583117 | |
| Pubmed | 2.19e-09 | 5 | 22 | 3 | 23677998 | ||
| Pubmed | 2.19e-09 | 5 | 22 | 3 | 15032598 | ||
| Pubmed | CD1 genotyping of patients with Mycobacterium malmoense pulmonary disease. | 2.19e-09 | 5 | 22 | 3 | 11580851 | |
| Pubmed | 2.19e-09 | 5 | 22 | 3 | 10488738 | ||
| Pubmed | 2.19e-09 | 5 | 22 | 3 | 3097645 | ||
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 38579449 | ||
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 20954848 | ||
| Pubmed | CD1A and CD1E gene polymorphisms are associated with susceptibility to multiple sclerosis. | 3.82e-07 | 2 | 22 | 2 | 21496400 | |
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 3053166 | ||
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 29301656 | ||
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 22782895 | ||
| Pubmed | Susceptibility to Guillain-Barré syndrome is not associated with CD1A and CD1E gene polymorphisms. | 3.82e-07 | 2 | 22 | 2 | 18838176 | |
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 15864273 | ||
| Pubmed | Polymorphisms of CD1 genes in chronic dysimmune neuropathies. | 3.82e-07 | 2 | 22 | 2 | 17428545 | |
| Pubmed | Inhibition of CD1 antigen presentation by human cytomegalovirus. | 1.15e-06 | 3 | 22 | 2 | 18287231 | |
| Pubmed | Separate pathways for antigen presentation by CD1 molecules. | 1.15e-06 | 3 | 22 | 2 | 10626896 | |
| Pubmed | Upregulation and atypical expression of the CD1 molecules on monocytes in sickle cell disease. | 1.15e-06 | 3 | 22 | 2 | 15556687 | |
| Pubmed | CD1a-, b-, and c-restricted TCRs recognize both self and foreign antigens. | 1.15e-06 | 3 | 22 | 2 | 16272286 | |
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 33384157 | ||
| Pubmed | Susceptibility to Guillain-Barré syndrome is associated to polymorphisms of CD1 genes. | 1.15e-06 | 3 | 22 | 2 | 16820217 | |
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 23468110 | ||
| Pubmed | Polymorphism of CD1 and SH2D2A genes in inflammatory neuropathies. | 1.15e-06 | 3 | 22 | 2 | 21696499 | |
| Pubmed | Structure and expression of the human thymocyte antigens CD1a, CD1b, and CD1c. | 1.15e-06 | 3 | 22 | 2 | 2447586 | |
| Pubmed | Dysregulated CD1 profile in myeloid dendritic cells in CVID is normalized by IVIg treatment. | 1.15e-06 | 3 | 22 | 2 | 23766460 | |
| Pubmed | 2.29e-06 | 4 | 22 | 2 | 18624350 | ||
| Pubmed | Antigen presentation by CD1 and MHC-encoded class I-like molecules. | 2.29e-06 | 4 | 22 | 2 | 8729450 | |
| Pubmed | 2.29e-06 | 4 | 22 | 2 | 2701945 | ||
| Pubmed | Lipid presentation by human CD1 molecules and the diverse T cell populations that respond to them. | 2.29e-06 | 4 | 22 | 2 | 24556395 | |
| Pubmed | 2.29e-06 | 4 | 22 | 2 | 12415264 | ||
| Pubmed | 3.82e-06 | 5 | 22 | 2 | 18337560 | ||
| Pubmed | 5.72e-06 | 6 | 22 | 2 | 12387869 | ||
| Pubmed | 8.01e-06 | 7 | 22 | 2 | 22003931 | ||
| Pubmed | 1.07e-05 | 8 | 22 | 2 | 12019269 | ||
| Pubmed | 3.46e-05 | 14 | 22 | 2 | 12563287 | ||
| Pubmed | 3.46e-05 | 14 | 22 | 2 | 20403135 | ||
| Pubmed | 3.09e-04 | 41 | 22 | 2 | 22904065 | ||
| Interaction | KCNJ8 interactions | 1.26e-05 | 44 | 21 | 3 | int:KCNJ8 | |
| Interaction | MAN1A2 interactions | 1.64e-05 | 48 | 21 | 3 | int:MAN1A2 | |
| Interaction | SGCB interactions | 9.77e-05 | 87 | 21 | 3 | int:SGCB | |
| Interaction | B2M interactions | 1.15e-04 | 92 | 21 | 3 | int:B2M | |
| Interaction | DPAGT1 interactions | 1.75e-04 | 19 | 21 | 2 | int:DPAGT1 | |
| Cytoband | 1q22-q23 | 2.72e-08 | 13 | 22 | 3 | 1q22-q23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q23 | 1.69e-04 | 226 | 22 | 3 | chr1q23 | |
| GeneFamily | C1-set domain containing | 5.86e-08 | 42 | 17 | 4 | 591 | |
| GeneFamily | Pyrin domain containing|Pyrin and HIN domain family | 2.46e-04 | 25 | 17 | 2 | 994 | |
| GeneFamily | NLR family | 2.46e-04 | 25 | 17 | 2 | 666 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 5.56e-03 | 394 | 17 | 3 | 471 | |
| Coexpression | FERRANDO_HOX11_NEIGHBORS | 8.99e-07 | 23 | 22 | 3 | M2059 | |
| Coexpression | TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_DN | 1.38e-05 | 56 | 22 | 3 | M14036 | |
| Coexpression | GSE27859_MACROPHAGE_VS_CD11C_INT_F480_INT_DC_DN | 2.12e-05 | 199 | 22 | 4 | M8587 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_T_ALPHA_BETA_ENTRY_CELL | 2.71e-05 | 70 | 22 | 3 | M45777 | |
| Coexpression | LEE_EARLY_T_LYMPHOCYTE_UP | 1.07e-04 | 111 | 22 | 3 | M7357 | |
| Coexpression | SU_THYMUS | 1.27e-04 | 20 | 22 | 2 | M13095 | |
| Coexpression | DESCARTES_MAIN_FETAL_THYMOCYTES | 1.39e-04 | 121 | 22 | 3 | M40144 | |
| Coexpression | WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP | 2.16e-04 | 26 | 22 | 2 | M8924 | |
| Coexpression | FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_336HR_DN | 3.29e-04 | 32 | 22 | 2 | M40918 | |
| Coexpression | MTOR_UP.N4.V1_DN | 4.75e-04 | 184 | 22 | 3 | M2756 | |
| Coexpression | LI_PBMC_MENACTRA_AGE_18_45YO_CORRELATED_WITH_ANTI_DT_ANTIBODY_3DY_POSITIVE | 5.15e-04 | 40 | 22 | 2 | M41037 | |
| Coexpression | GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_KO_4H_DN | 5.71e-04 | 196 | 22 | 3 | M8717 | |
| Coexpression | GSE26030_UNSTIM_VS_RESTIM_TH17_DAY5_POST_POLARIZATION_DN | 5.88e-04 | 198 | 22 | 3 | M8581 | |
| Coexpression | GSE37532_TREG_VS_TCONV_PPARG_KO_CD4_TCELL_FROM_LN_DN | 5.97e-04 | 199 | 22 | 3 | M8960 | |
| Coexpression | GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_DC_DN | 5.97e-04 | 199 | 22 | 3 | M5219 | |
| Coexpression | GSE44732_UNSTIM_VS_IL27_STIM_IMATURE_DC_UP | 6.06e-04 | 200 | 22 | 3 | M9699 | |
| Coexpression | GSE22886_DC_VS_MONOCYTE_UP | 6.06e-04 | 200 | 22 | 3 | M4471 | |
| Coexpression | GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_6H_UP | 6.06e-04 | 200 | 22 | 3 | M9922 | |
| Coexpression | GSE42088_UNINF_VS_LEISHMANIA_INF_DC_8H_UP | 6.06e-04 | 200 | 22 | 3 | M9909 | |
| Coexpression | GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA2_STIM_CD8_TCELL_DN | 6.06e-04 | 200 | 22 | 3 | M8039 | |
| Coexpression | GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_DC_DN | 6.06e-04 | 200 | 22 | 3 | M5216 | |
| Coexpression | FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_192HR_UP | 6.51e-04 | 45 | 22 | 2 | M40886 | |
| ToppCell | normal_Lung-Myeloid_cells-Pleural_Mac|normal_Lung / Location, Cell class and cell subclass | 1.05e-06 | 159 | 22 | 4 | f95a5570bf153fc5c598aba855db6b47ba818463 | |
| ToppCell | Dendritic_Cells-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 1.15e-06 | 163 | 22 | 4 | 5fff3932c1c259010e3add7a3b2301df2fa37df1 | |
| ToppCell | Dendritic_Cells-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 1.30e-06 | 168 | 22 | 4 | 33618e5dbcee31f30afacacc9f6046782c100fb3 | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_DC-DC-DC3|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.57e-06 | 176 | 22 | 4 | 7762e5d7c11756da605a604a289216bb53e25869 | |
| ToppCell | metastatic_Brain-Myeloid_cells-Pleural_Mac|metastatic_Brain / Location, Cell class and cell subclass | 1.71e-06 | 180 | 22 | 4 | 7de1c8ab1152fa517c6b4830d93ff53a19fca3d7 | |
| ToppCell | CTRL-Myeloid-cDC|Myeloid / Disease state, Lineage and Cell class | 1.79e-06 | 182 | 22 | 4 | ee137574b8f0e684a4a7cb26226877c471cae433 | |
| ToppCell | Dendritic_Cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.83e-06 | 183 | 22 | 4 | dd09e39e8ca282ff0f470e0652d519e190badd0b | |
| ToppCell | CTRL-Myeloid-cDC|CTRL / Disease state, Lineage and Cell class | 1.83e-06 | 183 | 22 | 4 | 20c4d16de7e090df3556a4458f783383a26871b6 | |
| ToppCell | CF-Myeloid-cDC|CF / Disease state, Lineage and Cell class | 1.91e-06 | 185 | 22 | 4 | 7f3d118845ff9f5f525796b0bbc6532a8ee323ab | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-cDC2-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.17e-06 | 191 | 22 | 4 | 7bad04f8afa949ea952c5c0d71eec43271ade680 | |
| ToppCell | wk_15-18-Hematologic-Myeloid-Cycling_DC|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.26e-06 | 193 | 22 | 4 | 8e6d31546f7150ab3e8ad4fde075839e6c33842a | |
| ToppCell | Dendritic_Cells|World / lung cells shred on cell class, cell subclass, sample id | 2.26e-06 | 193 | 22 | 4 | 7792eb6e247af2d7a8f80476f37dcd880922d625 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Dendritic-CD1c-positive_myeloid_dendritic_cell-DC2_(CD1c+_dendritic_cell)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.35e-06 | 195 | 22 | 4 | 66f3b3e15eaa21bc7cf2f204cac81de1a160a748 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Dendritic-CD1c-positive_myeloid_dendritic_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.35e-06 | 195 | 22 | 4 | 9cfbdb528088ad0ab100c7431c7d8f140a846de8 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Dendritic-CD1c-positive_myeloid_dendritic_cell-DC2_(CD1c+_dendritic_cell)-DC2_L.1.2.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.35e-06 | 195 | 22 | 4 | bbf5f79be4fcea754328f1af7ee5625075248100 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.40e-06 | 196 | 22 | 4 | 9c942bf9fc78caa173d2c7de5fe4c17f076c623b | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Dendritic-CD1c-positive_myeloid_dendritic_cell-DC2_(CD1c+_dendritic_cell)-DC2_L.1.2.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.40e-06 | 196 | 22 | 4 | a979662356c922adafa33c27f943f0d7d7c84f3d | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Dendritic-CD1c-positive_myeloid_dendritic_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.40e-06 | 196 | 22 | 4 | 968c24b64318d4f4d769daaa89eb7d2de188ac03 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Dendritic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.40e-06 | 196 | 22 | 4 | 14d68cd628f238395f0e8200e753a4f5daf8902c | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.40e-06 | 196 | 22 | 4 | fe7410c639fe4d7df3f6dcdb058b9a38b712927e | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Dendritic-CD1c-positive_myeloid_dendritic_cell-DC2_(CD1c+_dendritic_cell)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.40e-06 | 196 | 22 | 4 | 3b9f8fce7a60a88701d0ecd684199c4f7c640479 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Dendritic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.40e-06 | 196 | 22 | 4 | 787088ce800d7148bad7265a971797da597b029a | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Dendritic-CD1c-positive_myeloid_dendritic_cell-DC2_(CD1c+_dendritic_cell)-DC2_L.1.2.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.45e-06 | 197 | 22 | 4 | 515a2d0ee2bd3fc0a5a0c315e2b0c752e6af7406 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Dendritic-CD1c-positive_myeloid_dendritic_cell-DC2_(CD1c+_dendritic_cell)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.45e-06 | 197 | 22 | 4 | 4fccdc69ab4b966de6465f06677435e6f6e6abcd | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-cDC2-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.45e-06 | 197 | 22 | 4 | 4f7c10a636646dfc82a84026c1b5a36603367abe | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Dendritic-CD1c-positive_myeloid_dendritic_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.45e-06 | 197 | 22 | 4 | bfa04e5f4156a01df4217b1f59676edb0a7563e1 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-cDC2|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.50e-06 | 198 | 22 | 4 | da36c1bb62fdd1da7aca9c5115432a87fb48adb0 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Myeloid-Dendritic_cell-DC_activated|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.03e-05 | 124 | 22 | 3 | e16be7805c91db12b1110c90cd39492913f1d3ea | |
| ToppCell | TCGA-Thymus|World / Sample_Type by Project: Shred V9 | 3.10e-05 | 125 | 22 | 3 | 109857418118020d35f05a5eb8a25bb7e3d8ed2a | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_DC-DC-DC3|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.26e-05 | 139 | 22 | 3 | c320847311ba9a844fc4760251372a2a9152787b | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_dendritic-dendritic_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.54e-05 | 142 | 22 | 3 | 8b5441d0564e67ab4db58d9082909b5dab430a28 | |
| ToppCell | metastatic_Brain-Myeloid_cells-Pleural_Mac|Myeloid_cells / Location, Cell class and cell subclass | 4.73e-05 | 144 | 22 | 3 | 6f1158c85e1d50ef6f2c67abdb2dc855a9786b9a | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Degenerative_Connecting_Tubule_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.77e-05 | 154 | 22 | 3 | 9316732964a819a8e935a952faa3823109f90b77 | |
| ToppCell | Control-Myeloid-DC_Langerhans|Control / Disease state, Lineage and Cell class | 6.00e-05 | 156 | 22 | 3 | 58f371722d21005a9be2e67844ec2e5fec6e31e5 | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Tall_Cell-1|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 6.00e-05 | 156 | 22 | 3 | 45a05c7a45a3ec8551818ab67f18b3b9553934c1 | |
| ToppCell | metastatic_Brain-Myeloid_cells-Undetermined|Myeloid_cells / Location, Cell class and cell subclass | 6.11e-05 | 157 | 22 | 3 | 6ce7f2ea613e7f8e771860e8c0512274e4f54369 | |
| ToppCell | Control-Myeloid-DC_Langerhans|World / Disease state, Lineage and Cell class | 6.23e-05 | 158 | 22 | 3 | ec425ec7b8e3c527b4bbe57908d84528b9747796 | |
| ToppCell | COPD-Myeloid-DC_Langerhans|COPD / Disease state, Lineage and Cell class | 6.23e-05 | 158 | 22 | 3 | 71af1319eec34bf7bc9361ec9ef720c280ce97d1 | |
| ToppCell | Control-Myeloid-DC_Langerhans|Myeloid / Disease state, Lineage and Cell class | 6.47e-05 | 160 | 22 | 3 | 174775fb5cc7b478c6cd04f7c565738648ec2fc3 | |
| ToppCell | COPD-Myeloid-DC_Langerhans|World / Disease state, Lineage and Cell class | 6.47e-05 | 160 | 22 | 3 | 1b73a14ad6546d9f2812c19081278a79260abeae | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_12|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.59e-05 | 161 | 22 | 3 | 1d446f5ba57d84949823a35cbedaee8f448fe40f | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-cDC2-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.59e-05 | 161 | 22 | 3 | 1e9b833a20f5fb936a71cab24c87ff24bc3c8942 | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_12|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.59e-05 | 161 | 22 | 3 | 1670108afc0af90861eb80a84e59995571c0da1b | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-T_&_ILC-T_entry|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 6.71e-05 | 162 | 22 | 3 | a27750117e7f16a0bd07cc5f58a56becb39e800b | |
| ToppCell | tumor_Lung-Myeloid_cells-Pleural_Mac|tumor_Lung / Location, Cell class and cell subclass | 6.71e-05 | 162 | 22 | 3 | 9ac3242511315224ed94582aca9e9a3786cd01a0 | |
| ToppCell | COPD-Myeloid-DC_Langerhans|Myeloid / Disease state, Lineage and Cell class | 6.96e-05 | 164 | 22 | 3 | a07c6e13c07a90bc37db0915eb14931eb8309a1e | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.21e-05 | 166 | 22 | 3 | d373f1092e85eeb317a7406032b259f11e6adbe0 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.21e-05 | 166 | 22 | 3 | f453a1d545d59003d98485ac31e85e6cf451817c | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-Myeloid-cDC2|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.34e-05 | 167 | 22 | 3 | 1bd0aa7a3c8649f342bb856cf861c4c5984ad889 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_dendritic|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.34e-05 | 167 | 22 | 3 | ecdbfde870a2a44c44b9dd65a8737afc6fbf816c | |
| ToppCell | ILEUM-non-inflamed-(3)_mature_DC|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 7.74e-05 | 170 | 22 | 3 | 60151394460e6f27a42fab434e8b7b2adc78b128 | |
| ToppCell | metastatic_Brain-Myeloid_cells-CD207+CD1a+_LCs|Myeloid_cells / Location, Cell class and cell subclass | 8.01e-05 | 172 | 22 | 3 | 38d17e769fe8eac8b57b820490d4ddd969243ee7 | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Tall_Cell|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 8.15e-05 | 173 | 22 | 3 | 2e9dc137f3675eee07f941eb4cfcaf24a83ab0fb | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_DC-DC-DC2|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 8.29e-05 | 174 | 22 | 3 | 60ee7c6f1b6972e6647a16848087cc60e0060bbe | |
| ToppCell | Dendritic_Cells-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 8.44e-05 | 175 | 22 | 3 | 584290a51f9975782a5ac8c6ad67c778d8323f8c | |
| ToppCell | Dendritic_Cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 8.72e-05 | 177 | 22 | 3 | d2cd081bdda0eba9f6f6473c4d3939e4bee3440e | |
| ToppCell | BAL-Severe-cDC_3|Severe / Compartment, Disease Groups and Clusters | 8.72e-05 | 177 | 22 | 3 | 939487a05311b66edfc3f44a7955fbf25266d6bf | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-T_cells-SELL+_CD4_T|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.72e-05 | 177 | 22 | 3 | 7d73643beb007032e757f2611121c4f3027aecf5 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Dendritic-dendritic_cell-Migratory_DCs-Migratory_DCs_L.1.2.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.72e-05 | 177 | 22 | 3 | d78a6003ce2d15d7771ae385de252eec7e3c3eea | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Dendritic-dendritic_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.72e-05 | 177 | 22 | 3 | aa56129d2d5a73a10e33b7162233a4d9337ee535 | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-Myeloid-cDC2|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.72e-05 | 177 | 22 | 3 | 23c1bce4ae3b94f56263f5a9f6bbd1805c097a12 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Dendritic-dendritic_cell-Migratory_DCs|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.72e-05 | 177 | 22 | 3 | 70ca5b6fde2e38af1eb88a7d6e8746edba298191 | |
| ToppCell | Dendritic_Cells-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 8.87e-05 | 178 | 22 | 3 | 61ce3ec64c4cffceac08412e20c26e9c90ab8197 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-Myeloid-cDC2|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.87e-05 | 178 | 22 | 3 | 32120936a524c38e621bd2fca17524fef74422e0 | |
| ToppCell | Dendritic_Cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 8.87e-05 | 178 | 22 | 3 | 3a28103cf282cc3637d1875a3b4cd7ddf3207687 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-CD207+CD1a+_LCs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 9.17e-05 | 180 | 22 | 3 | 289f8c4b53ffd164fee1f459a9315c0deb5f76d0 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Hematopoietic-T_cells-SELL+_CD4_T|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.17e-05 | 180 | 22 | 3 | 702673c0b7c5b0d22a6af3884374804b8c4d6254 | |
| ToppCell | metastatic_Brain-Myeloid_cells-CD207+CD1a+_LCs|metastatic_Brain / Location, Cell class and cell subclass | 9.17e-05 | 180 | 22 | 3 | 51727cb66fe7a7709453f7026e0ff3d6c93d5aa5 | |
| ToppCell | tumor_Lung-Myeloid_cells-CD207+CD1a+_LCs|tumor_Lung / Location, Cell class and cell subclass | 9.47e-05 | 182 | 22 | 3 | 243779ba1009097f8fafa1a691e296ec3aeefc04 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-CD1c+_DCs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 9.47e-05 | 182 | 22 | 3 | 551d301adfb4d5046c5f60f6996450621b04e9b2 | |
| ToppCell | IPF-Myeloid-DC_Langerhans|World / Disease state, Lineage and Cell class | 9.47e-05 | 182 | 22 | 3 | 0e8cfbd8ea196f27a227dbb4d2eb93bc48d27922 | |
| ToppCell | Dendritic_Cells-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 9.63e-05 | 183 | 22 | 3 | 499da89b4abe7b746e703cd1e5c56f9b1d97ac3c | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.63e-05 | 183 | 22 | 3 | d73cac83cde82665f110baad7cf28db75f9ffe52 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-CD163+CD14+_DCs|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 9.79e-05 | 184 | 22 | 3 | 2dc4b2a9970111ed5e2977fc178595a12d7bb59d | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_2|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.79e-05 | 184 | 22 | 3 | 0a26bcc6610f756939e32a4d6dfeebcbf3a1db86 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.79e-05 | 184 | 22 | 3 | 1c56378b3888c46258d446b47de4d6282fe74b0d | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.79e-05 | 184 | 22 | 3 | a45980306c4e697a2703bed72a7b48fb23d942f4 | |
| ToppCell | IPF-Myeloid-DC_Langerhans|IPF / Disease state, Lineage and Cell class | 9.94e-05 | 185 | 22 | 3 | f8ee3cb2aa9ec70f9ce8797be2b155da27ef6464 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Dendritic-CD1c-positive_myeloid_dendritic_cell-DC2_(CD1c+_dendritic_cell)-DC2_L.1.2.1.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.94e-05 | 185 | 22 | 3 | 7cf69717b88347833819c161ca89e751416f6c67 | |
| ToppCell | IPF-Myeloid-DC_Langerhans|Myeloid / Disease state, Lineage and Cell class | 9.94e-05 | 185 | 22 | 3 | ced17f69486591c3cbbdc852a3e82c3f3a4a30d7 | |
| ToppCell | 10x5'-GI_small-bowel-Myeloid_Dendritic-DC2|GI_small-bowel / Manually curated celltypes from each tissue | 9.94e-05 | 185 | 22 | 3 | f78be85dd6e443abb7af20f98ff351c1131ece4d | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_2|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.94e-05 | 185 | 22 | 3 | fec16a5e527fdef32d25957451b6e8ee9796cafd | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Dendritic-CD1c-positive_myeloid_dendritic_cell-DC2_(CD1c+_dendritic_cell)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.01e-04 | 186 | 22 | 3 | 5d1d77825b85f80de20d7b91418820c6dbdab84a | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Dendritic-CD1c-positive_myeloid_dendritic_cell-DC2_(CD1c+_dendritic_cell)-DC2_L.1.2.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.01e-04 | 186 | 22 | 3 | 0c55248b4a9f9bcc32a7e94329aea80796fd4a38 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Dendritic-CD1c-positive_myeloid_dendritic_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.01e-04 | 186 | 22 | 3 | 61b5300f2d9b02e4c850642e4cae3648af46772f | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Dendritic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.04e-04 | 188 | 22 | 3 | 649d27b2ef735b481ec0ed4f7a9b39aacc472a78 | |
| ToppCell | LAM-Myeloid-DC|LAM / Condition, Lineage and Cell class | 1.04e-04 | 188 | 22 | 3 | b4140110c2f7d25fd8a0d2749e33e02003ac4bf2 | |
| ToppCell | 3'_v3-Lung-Myeloid_Dendritic-Cycling_Dendritic|Lung / Manually curated celltypes from each tissue | 1.04e-04 | 188 | 22 | 3 | 0e8ac42c439f30a05e015210e1d5c2dcb9d9d471 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-CD163+CD14+_DCs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 1.04e-04 | 188 | 22 | 3 | 5d12afb483d028ca02b3b4215131f6128e8bcd48 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_dendritic-dendritic_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.06e-04 | 189 | 22 | 3 | e97c64609b1f8158d750edb869df56e5bd10538b | |
| ToppCell | 3'_v3-Lung-Myeloid_Dendritic-DC2|Lung / Manually curated celltypes from each tissue | 1.08e-04 | 190 | 22 | 3 | 468525c05e38158a3b8a445882b2d63dfb1d2c63 | |
| ToppCell | tumor_Lung-Myeloid_cells-CD207+CD1a+_LCs|Myeloid_cells / Location, Cell class and cell subclass | 1.08e-04 | 190 | 22 | 3 | 58a6ab70737d719ca9725ac087f20dfe9be0463e | |
| ToppCell | (2)_Dendritic_Cells|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 1.08e-04 | 190 | 22 | 3 | 5163a5be95fb6c2609bfa3d69166af172f74e724 | |
| ToppCell | Control-Myeloid-cDC2|Control / Disease state, Lineage and Cell class | 1.08e-04 | 190 | 22 | 3 | 4e481e42353d47af7991744000403af2873f6a41 | |
| ToppCell | 368C-Myeloid-Dendritic-cDC2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.09e-04 | 191 | 22 | 3 | 85dba3a8a52307df52d1d78a6f278501298f3067 | |
| ToppCell | (3)_MNP-(3)_DC_2|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.09e-04 | 191 | 22 | 3 | 3ff163484af8c12ef4eef87246cf044257fd2547 | |
| ToppCell | COVID-19-Myeloid-DC2|COVID-19 / Condition, Lineage and Cell class | 1.09e-04 | 191 | 22 | 3 | 1304ab7b5713f29f3966ffc020ea1b52e8e2f375 | |
| ToppCell | Dendritic_Cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.09e-04 | 191 | 22 | 3 | b51c8ff1279581088557bb36760c70209c77148c | |
| ToppCell | COPD-Myeloid-cDC2|COPD / Disease state, Lineage and Cell class | 1.09e-04 | 191 | 22 | 3 | 2af6e4a6bd1f2193ece2131c3b7d976dd23a6966 | |
| ToppCell | IPF-Myeloid-cDC2|World / Disease state, Lineage and Cell class | 1.09e-04 | 191 | 22 | 3 | 9fda87fb6bc5b8b6c0214ec909ebbc9f3f65319b | |
| Drug | mycobactin | 5.02e-06 | 35 | 22 | 3 | CID005748534 | |
| Drug | ethyl phosphate | 1.33e-05 | 6 | 22 | 2 | CID000074190 | |
| Drug | NA-1 | 2.85e-05 | 62 | 22 | 3 | CID000446091 | |
| Drug | Cefotiam hydrochloride; Up 200; 7.2uM; PC3; HT_HG-U133A | 3.59e-05 | 198 | 22 | 4 | 6762_UP | |
| Drug | Lycorine hydrochloride [2188-68-3]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 3.66e-05 | 199 | 22 | 4 | 3891_DN | |
| Disease | neurofilament light chain measurement | 8.87e-06 | 57 | 21 | 3 | EFO_0009178 | |
| Disease | non-alcoholic fatty liver disease severity measurement | 1.80e-04 | 28 | 21 | 2 | EFO_0008421 | |
| Disease | HVA measurement, 5-HIAA measurement | 3.52e-04 | 39 | 21 | 2 | EFO_0005131, EFO_0005132 | |
| Disease | chronic obstructive pulmonary disease (is_implicated_in) | 9.18e-04 | 63 | 21 | 2 | DOID:3083 (is_implicated_in) | |
| Disease | liver cirrhosis (is_marker_for) | 1.55e-03 | 82 | 21 | 2 | DOID:5082 (is_marker_for) | |
| Disease | information processing speed | 1.66e-03 | 85 | 21 | 2 | EFO_0004363 | |
| Disease | asthma (is_implicated_in) | 5.53e-03 | 157 | 21 | 2 | DOID:2841 (is_implicated_in) | |
| Disease | birth weight, parental genotype effect measurement | 8.15e-03 | 192 | 21 | 2 | EFO_0004344, EFO_0005939 | |
| Disease | Prostatic Neoplasms | 9.10e-03 | 616 | 21 | 3 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 9.10e-03 | 616 | 21 | 3 | C0376358 | |
| Disease | monocyte count | 1.30e-02 | 1320 | 21 | 4 | EFO_0005091 | |
| Disease | neutrophil count | 1.51e-02 | 1382 | 21 | 4 | EFO_0004833 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| WRMIWEQNTGIIVMI | 936 | P23470 | |
| QQKWMHSLPNDWIME | 111 | Q9P1Z9 | |
| PKPVWVMWMRGEQEQ | 231 | P29016 | |
| DGQVMWWDIRKMSEP | 286 | Q9GZS0 | |
| AVLRWIKGEMWQNMI | 166 | P59045 | |
| KPVWVMWMRGEQEQQ | 231 | P06126 | |
| MGQIEWAMWANEQAL | 1 | P13498 | |
| PEQEQLMVVWLSWMI | 446 | Q9H0H0 | |
| MWKWLQEPEFQRMSA | 391 | O95948 | |
| MWKSWPGDSKEVQVM | 171 | Q9NX02 | |
| WVMWMRGEQEQRGTQ | 241 | P15812 | |
| QGRWTNMERMQLWAM | 126 | Q8NEV9 | |
| MWQRGMWQPGMSQQV | 436 | Q86VE3 | |
| PDVQRWWMMLQPQFK | 106 | Q16842 | |
| WMENMPEGKWPNWMI | 431 | Q07837 | |
| MEELEQGLLMQPWAW | 1 | Q9H9Q4 | |
| EAQKWNQPWLEFDMM | 256 | P49406 | |
| GNWERKRPVWVMLMV | 156 | A6NFA1 | |
| EKMEQLWRNPWVGMC | 766 | Q5HYM0 | |
| MGLWRQVEGMEDWKQ | 71 | P25311 | |
| QAIWMMDPKDVREWQ | 296 | Q12931 | |
| VGTEWRWKMDQPEMI | 431 | Q9NV66 |